Addington, J. & Addington, D. (1999) Neurocognitive and social functioning in schizophrenia. Schizophrenia Bulletin, 25, 173–182.
Addington, J., Addington, D. & Maticka-Tyndale, E. (1991) Cognitive functioningand positive and negative symptoms in schizophrenia. Schizophrenia Research, 5, 123–134.
Andreasen, N. C. (1997) The evolving concept of schizophrenia: from Kraepelin to the present and future. Schizophrenia Research, 28, 105–109.
Bart, A. E. (2004) Pre-attentive processing and schizophrenia: animal studies. Psychopharmacology, 174, 65–74.
Bilder, R. M., Goldman, R. S., Robinson, D., et al (2000) Neuropsychology of first-episode schizophrenia: initial characterization and clinical correlates. American Journal of Psychiatry, 157, 549–559.
Blyler, C. R., Gold, J. M., Iannone, V. N., et al (2000) Short form of the WAIS-III for use with patients with schizophrenia. Schizophrenia Research, 46, 209–215.
Bunney, W. E. & Bunney, B. G. (2000) Evidence for a compromised dorsolateral prefrontal cortical parallel circuit in schizophrenia. Brain Research Reviews, 31, 138–146.
Carlsson, R., Nyman, H., Ganse, G., et al (2006) Neuropsychological functions predict 1-and 3-year outcome in first-episode psychosis. Acta Psychiatrica Scandinavica, 113, 102–111.
Clementz, B. A., McDowell, J. E. & Zisook, S. (1994) Saccadic system functioning among schizophrenia patients and their first-degree biological relatives. Journal of Abnormal Psychology, 103, 277–287.
Dickinson, D., Iannone, V. N., Wilk, C. M., et al (2004) General and specific cognitive deficits in schizophrenia. Biological Psychiatry, 55, 826–833.
Everling, S. & Fischer, B. (1998) The antisaccade: a review of basic research and clinical studies. Neuropsychologia, 36, 885–899.
Fukushima, J., Fukushima, K., Miyasaka, K., et al (1994) Voluntary control of saccadic eye movement in patients with frontal cortical lesions and parkinsonian patients in comparison with that in schizophrenics. Biological Psychiatry, 36, 21–30.
Gabriele, S.-I. (2000) Epistemological aspects of Eugen Bleulers conception of schizophrenia in 1911. Medicine, Health Care and Philosophy, 3, 153–159.
Gold, J. M., Queern, C., Iannone, V. N., et al (1999) Repeatable battery for the assessment of neuropsychological status as a screening test in schizophrenia. I. Sensitivity, reliability, and validity. American Journal of Psychiatry, 156, 1944–1950.
Goldberg, T. E., Weinberger, D. R., Berman, K. F., et al (1987) Further evidence for dementia of the prefrontal type in schizophrenia? A controlled study of teaching the Wisconsin Card Sorting Test. Archives of General Psychiatry, 44, 1008–1014.
Goldberg, T. E., Torrey, E. F., Gold, J. M., et al (1993) Learning and memory in monozygotic twins discordant for schizophrenia. Psychological Medicine, 23, 71–85.
Goldman-Rakic, P. S. (1994) Working memory dysfunction in schizophrenia. Journal of Neuropsychiatry and Clinical Neuroscience, 6, 348–357.
Green, M. F. (1996) What are the functional consequences of neurocognitive deficits in schizophrenia?
American Journal of Psychiatry, 153, 321–330.
Green, M. F., Kern, R. S., Braff, D. L., et al (2000) Neurocognitive deficits and functional outcome in schizophrenia: are we measuring the “right stuff”?
Schizophrenia Bulletin, 26, 119–136.
Green, M. F., Kern, R. S. & Heaton, R. K. (2004) Longitudinal studies of cognition and functional outcome in schizophrenia: implications for MATRICS. Schizophrenia Research, 72, 41–51.
Harvey, P. D. & Keefe, R. S. (1997) Cognitive impairment in schizophrenia and implications of atypical neuroleptic treatment. CNS Spectrums, 2, 1–11.
Harvey, P. D., Green, M. F., McGurk, S. R., et al (2003) Changes in cognitive functioning with risperidone and olanzapine treatment: a large-scale, double-blind, randomized study. Psychopharmacology, 169, 404–411.
Harvey, P. D., Siu, C. O. & Romano, S. (2004) Randomized, controlled, double-blind, multicenter comparison of the cognitive effects of ziprasidone versus olanzapine in acutely ill inpatients with schizophrenia or schizoaffective disorder. Psychopharmacology, 172, 324–332.
Heaton, R. K., Gladsjo, J. A., Palmer, B. W., et al (2001) Stability and course of neuropsychological deficits in schizophrenia. Archives of General Psychiatry, 58, 24–32.
Heinrichs, R. W. & Zakzanis, K. K. (1998) Neurocognitive deficit in schizophrenia: a quantitative review of the evidence. Neuropsychology, 12, 426–445.
Hobart, M. P., Goldberg, R., Bartko, J. J., et al (1999) Repeatable battery for the assessment of neuropsychological status as ascreening test in Schizophrenia. II. Convergent/discriminant validity and diagnostic group comparisons. American Journal of Psychiatry, 156, 1951–1957.
Hoenig, J. (1983) The concept of schizophrenia. Kraepelin – Bleuler–Schneider. British Journal of Psychiatry, 142, 547–556.
Kathmann, N., Hochrein, A., Uwer, R., et al (2003) Deficits in gain of smooth pursuit eye movements in schizophrenia and affective disorder patients and their unaffected relatives. American Journal of Psychiatry, 160, 696–702.
Keefe, R. S. (1995) The contribution of neuropsychology to psychiatry. American Journal of Psychiatry, 152, 6–15.
Keefe, R. S. E., Goldberg, T. E., Harvey, P. D., et al (2004) The Brief Assessment of Cognition in Schizophrenia: reliability, sensitivity, and comparison with a standard neurocognitive battery. Schizophrenia Research, 68, 283–297.
Keefe, R. S., Eesley, C. E. & Poe, M. P. (2005) Defining a cognitive function decrement in schizophrenia. Biological Psychiatry, 57, 688–691.
Keefe, R. S., Bilder, R. M., Harvey, P. D., et al (2006a) Baseline neurocognitive deficits in the CATIE schizophrenia trial. Neuropsychopharmacology, 31, 2033–2046.
Keefe, R. S.
Poe, M., Walker, T. M., et al (2006b) The Schizophrenia Cognition Rating Scale: an interview-based assessment and its relationship to cognition, real-world functioning, and functional capacity. American Journal of Psychiatry, 163, 426–432.
Keefe, R. S., Poe, M., Walker, T. M., et al (2006c) The relationship of the Brief Assessment of Cognition in Schizophrenia (BACS) to functional capacity and real-world functional outcome. Journal of Clinical and Experimental Neuropsychology, 28, 260–269.
Keefe, R. S. E., Sweeney, J. A., Gu, H., et al (2007) A comparison of the effects of olanzapine, quetiapine, and risperidone on neurocognitive function in first-episode psychosis. A randomized, double-blind clinical trial. American Journal of Psychiatry, 164, 1061–1071.
Marder, S. R. & Fenton, W. (2004) Measurement and treatment research to improve cognition in schizophrenia: NIMH MATRICS initiative to support the development of agents for improving cognition in schizophrenia. Schizophrenia Research, 72, 5–9.
Menditto, A. A., Wallace, C. J., Liberman, R. P., et al (1999) Functional assessment of independent living skills. Psychiatric Rehabilitation Skills, 3, 200–219.
Mohamed, S., Paulsen, J. S., O'Leary, D., et al (1999) Generalized cognitive deficits in schizophrenia: a study of first-episode patients. Archives of General Psychiatry, 56, 749–754.
Nuechterlein, K. H. & Green, M. F. (2006) MATRICS Consesus Cognitive Battery Manual.
Palmer, B. W., Heaton, R. K., Paulsen, J. S., et al (1997) Is it possible to be schizophrenic yet neuropsychologically normal?
Neuropsychology, 11, 437–446.
Patterson, T. L., Goldman, S., McKibbin, C. L., et al (2001) UCSD performance-based skills assessment: development of a new measure of everyday functioning for severely mentally ill adults. Schizophrenia Bulletin, 27, 235–245.
Radant, A. D., Dobie, D. J., Calkins, M. E., et al (2007) Successful multi-site measurement of antisaccade performance deficits in schizophrenia. Schizophrenia Research, 89, 320–329.
Randolph, C. (1998) Repeatable Battery for the Assessment of Neuropsychological Status.
Rosenberg, D. R., Sweeney, J. A., Squires-Wheeler, E., et al (1997) Eye-tracking dysfunction in offspring from the New York High-Risk Project: diagnostic specificity and the role of attention. Psychiatry Research, 66, 121–130.
Ryan, J. J., Lopez, S. J. & Werth, T. R. (1998) Administration time estimated for WAIS–III subtests, scales, and short forms in a clinical sample. Journal of Psychoeducational Assessment, 16, 315–323.
Saykin, A. J., Gur, R. C., Gur, R. E., et al (1991) Neuropsychological function in schizophrenia. Selective impairment in memory and learning. Archives of General Psychiatry, 48, 618–624.
Saykin, A. J., Shtasel, D. L., Gur, R. E., et al (1994) Neuropsychological deficits in neuroleptic naive patients with first-episode schizophrenia. Archives of General Psychiatry, 51, 124–131.
Sweeney, J. A., Clementz, B. A., Haas, G. L., et al (1994) Eye tracking dysfunction in schizophrenia: characterization of component eye movement abnormalities, diagnostic specificity, and the role of attention. Journal of Abnormal Psychology, 103, 222–230.
Torrey, E. F. (2002) Studies of individuals with schizophrenia never treated with antipsychotic medications: a review. Schizophrenia Research, 58, 101–115.
Tulsky, D. S. & Price, L. R. (2003) The joint WAIIS–III and WMS–III factor structure: development and cross-validation of a six-factor model of cognitive functioning. Psychological Assessment, 15, 149–162.
Velligan, D. I., Mahurin, R. K., Diamond, P. L., et al (1997) The functional significance of symptomatology and cognitive function in schizophrenia. Schizophrenia Research, 25, 21–31.
Velligan, D. I., DiCocco, M., Bow-Thomas, C. C., et al (2004) A brief cognitive assessment for use with schizophrenia patients in community clinics. Schizophrenia Research, 71, 273–283.
Weber, B. (2003) RBANS has reasonable test–retest reliability in schizophrenia, Evidence-Based Mental Health, 6, 22.
Wechsler, D. (1997a) Wechsler Adult Intelligence Scale (3rd edn). Psychological Corporation.
Wechsler, D. (1997b) Wechsler Memory Scale (3rd edn). Psychological Corporation.
Wilk, C. M., Gold, J. M., Bartko, J. J., et al (2002) Test–retest stability of the repeatable battery for the assessment of neuropsychological status in schizophrenia. American Journal of Psychiatry, 159, 838–844.